Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity
Marja‐Riitta Taskinen, Sanni Söderlund, Leonie H. Bogl, et al.
Journal of Internal Medicine (2017) Vol. 282, Iss. 2, pp. 187-201
Open Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
François Mach, Colin Baigent, Alberico L. Catapano, et al.
European Heart Journal (2019) Vol. 41, Iss. 1, pp. 111-188
Open Access | Times Cited: 6829
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
François Mach, Colin Baigent, Alberico L. Catapano, et al.
Atherosclerosis (2019) Vol. 290, pp. 140-205
Open Access | Times Cited: 4166
Fructose metabolism and metabolic disease
Sarah Anissa Hannou, Danielle E. Haslam, Nicola M. McKeown, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 2, pp. 545-555
Open Access | Times Cited: 455
Dietary Fructose and the Metabolic Syndrome
Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén
Nutrients (2019) Vol. 11, Iss. 9, pp. 1987-1987
Open Access | Times Cited: 239
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
Hannele Yki‐Järvinen, Panu K. Luukkonen, Leanne Hodson, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 11, pp. 770-786
Open Access | Times Cited: 192
Molecular aspects of fructose metabolism and metabolic disease
Mark A. Herman, Morris J. Birnbaum
Cell Metabolism (2021) Vol. 33, Iss. 12, pp. 2329-2354
Open Access | Times Cited: 192
Fructose and hepatic insulin resistance
Samir Softic, Kimber L. Stanhope, Jérémie Boucher, et al.
Critical Reviews in Clinical Laboratory Sciences (2020) Vol. 57, Iss. 5, pp. 308-322
Open Access | Times Cited: 190
PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
Maciej Banach, Paweł Burchardt, Krzysztof Chlebus, et al.
Archives of Medical Science (2021) Vol. 17, Iss. 6, pp. 1447-1547
Open Access | Times Cited: 132
Disorders of lipid metabolism. Clinical Guidelines 2023
М. В. Ежов, В. В. Кухарчук, И. В. Сергиенко, et al.
Russian Journal of Cardiology (2023) Vol. 28, Iss. 5, pp. 5471-5471
Open Access | Times Cited: 96
The role of ChREBP in carbohydrate sensing and NAFLD development
Marion Régnier, Thaïs Carbinatti, Lucia Parlati, et al.
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 6, pp. 336-349
Closed Access | Times Cited: 45
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Jan Borén, Chris J. Packard, Marja‐Riitta Taskinen
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 120
INTERDISCIPLINARY CLINICAL PRACTICE GUIDELINES "MANAGEMENT OF OBESITY AND ITS COMORBIDITIES"
И. И. Дедов, Marina V. Shestakova, G. А. Melnichenko, et al.
Obesity and metabolism (2021) Vol. 18, Iss. 1, pp. 5-99
Open Access | Times Cited: 96
Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation
Giacomo Germani, Marie Laryea, Laura Rubbia‐Brandt, et al.
Transplantation (2018) Vol. 103, Iss. 1, pp. 57-67
Open Access | Times Cited: 83
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
Marja‐Riitta Taskinen, Chris J. Packard, Jan Borén
Current Atherosclerosis Reports (2019) Vol. 21, Iss. 8
Open Access | Times Cited: 82
Are Fruit Juices Healthier Than Sugar-Sweetened Beverages? A Review
Alexandra Pepin, Kimber L. Stanhope, Pascal Imbeault
Nutrients (2019) Vol. 11, Iss. 5, pp. 1006-1006
Open Access | Times Cited: 78
Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction
Jemy A. Gutierrez, Wei Liu, Sylvie Perez, et al.
Molecular Metabolism (2021) Vol. 48, pp. 101196-101196
Open Access | Times Cited: 65
Fructose impairs fat oxidation: Implications for the mechanism of western diet-induced NAFLD
Mustafa Kutlu Inci, Sehyung Park, Robert N. Helsley, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 114, pp. 109224-109224
Open Access | Times Cited: 39
Examining Prenylated Xanthones as Potential Inhibitors Against Ketohexokinase C Isoform for the Treatment of Fructose-Driven Metabolic Disorders: An Integrated Computational Approach
Tilal Elsaman, Magdi Awadalla Mohamed
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 126-126
Open Access | Times Cited: 1
Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories
Kimber L. Stanhope, Michael I. Goran, Anja Bosy‐Westphal, et al.
Obesity Reviews (2018) Vol. 19, Iss. 9, pp. 1205-1235
Open Access | Times Cited: 76
High Fructose Intake and Adipogenesis
Adrián Hernández-Díazcouder, Rodrigo Romero‐Nava, Roxana Carbó, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2787-2787
Open Access | Times Cited: 67
Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals
Giuseppe Della Pepa, Claudia Vetrani, Gianluca Lombardi, et al.
Nutrients (2017) Vol. 9, Iss. 10, pp. 1065-1065
Open Access | Times Cited: 64
Dietary carbohydrates and fatty liver disease
Sally Chiu, Kathleen Mulligan, Jean‐Marc Schwarz
Current Opinion in Clinical Nutrition & Metabolic Care (2018) Vol. 21, Iss. 4, pp. 277-282
Closed Access | Times Cited: 61
Tissue-Specific Fructose Metabolism in Obesity and Diabetes
Robert N. Helsley, F. Moreau, Manoj K. Gupta, et al.
Current Diabetes Reports (2020) Vol. 20, Iss. 11
Open Access | Times Cited: 51
Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
Bryant H. Keirns, Christina M. Sciarrillo, Nicholas A. Koemel, et al.
Journal of Nutritional Science (2021) Vol. 10
Open Access | Times Cited: 41
Current WHO recommendation to reduce free sugar intake from all sources to below 10% of daily energy intake for supporting overall health is not well supported by available evidence
Ruolin Yan, Chi Bun Chan, Jimmy Chun Yu Louie
American Journal of Clinical Nutrition (2022) Vol. 116, Iss. 1, pp. 15-39
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top